Literature DB >> 14746814

The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle.

Simone Mocellin1, Francesco Marincola, Carlo Riccardo Rossi, Donato Nitti, Mario Lise.   

Abstract

Interleukin-10 (IL-10) is a pleiotropic cytokine that modulates the function of several adaptive immunity-related cells. Although generally considered an immunosuppressive molecule, IL-10 possesses immunostimulatory properties in several in vitro and in vivo models. These very different outcomes are believed to depend upon experimental conditions, the dominant immune effector mediating a given immune response, the timing of IL-10 production/administration, and IL-10 dose and/or location of expression. In the present work, we review the current knowledge regarding IL-10 activity on adaptive immunity related cells, emphasize new insights on IL-10 molecular/cellular targets, and summarize the available data on the relationship between IL-10 and some pathological conditions (e.g. infectious diseases, autoimmunity, allergy, cancer and transplantation) involving adaptive immunity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14746814     DOI: 10.1016/j.cytogfr.2003.11.001

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  75 in total

1.  Pulsed high-dose dexamethasone improves interleukin 10 secretion by CD5+ B cells in patients with primary immune thrombocytopenia.

Authors:  Fanli Hua; Lili Ji; Yanxia Zhan; Feng Li; Shanhua Zou; Xiaoyun Wang; Dongli Song; Zhihui Min; Song Gao; Yangjiong Wu; Hao Chen; Yunfeng Cheng
Journal:  J Clin Immunol       Date:  2012-06-06       Impact factor: 8.317

2.  IVIg attenuates TLR-9 activation in B cells from SLE patients.

Authors:  Aharon Kessel; Regina Peri; Tharwat Haj; Ayelet Snir; Gleb Slobodin; Edmond Sabo; Itzhak Rosner; Yehuda Shoenfeld; Elias Toubi
Journal:  J Clin Immunol       Date:  2010-10-05       Impact factor: 8.317

3.  The IL-10 promoter haplotype and cancer risk: evidence from a meta-analysis.

Authors:  Kui Zhang; Lushun Zhang; Xianmin Wang; Lin Zhang
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

4.  Alternative mechanism by which IFN-gamma enhances tumor recognition: active release of heat shock protein 72.

Authors:  Maria A Bausero; Robert Gastpar; Gabriele Multhoff; Alexzander Asea
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

5.  Association of IL-10 level and IL-10 promoter SNPs with specific antibodies in penicillin-allergic patients.

Authors:  Hai-Ling Qiao; Qiang Wen; Na Gao; Xin Tian; Lin-Jing Jia
Journal:  Eur J Clin Pharmacol       Date:  2007-01-16       Impact factor: 2.953

6.  Association of the four common polymorphisms in interleukin-10 (rs1800890, rs1800896, rs1800871, and rs1800872) with non-Hodgkin's lymphoma risk: a meta-analysis.

Authors:  Zhi-Ming Dai; Ai-Li He; Wang-Gang Zhang; Jie Liu; Xing-Mei Cao; Yin-Xia Chen; Xiao-Rong Ma; Wan-Hong Zhao; Zhi-Jun Dai
Journal:  Int J Clin Exp Med       Date:  2014-12-15

7.  Ascites IL-10 Promotes Ovarian Cancer Cell Migration.

Authors:  Denis Lane; Isabelle Matte; Perrine Garde-Granger; Paul Bessette; Alain Piché
Journal:  Cancer Microenviron       Date:  2018-07-23

8.  Extended IL10 haplotypes and their association with HIV progression to AIDS.

Authors:  T K Oleksyk; S Shrestha; A L Truelove; J J Goedert; S M Donfield; J Phair; S Mehta; S J O'Brien; M W Smith
Journal:  Genes Immun       Date:  2009-03-19       Impact factor: 2.676

9.  IL-10 -1082 G>A: a risk for prostate cancer but may be protective against progression of prostate cancer in North Indian cohort.

Authors:  Pravin Kesarwani; Dinesh Kumar Ahirwar; Anil Mandhani; Anand Narayan Singh; Divakar Dalela; Anand Narain Srivastava; Rama D Mittal
Journal:  World J Urol       Date:  2009-01-15       Impact factor: 4.226

Review 10.  Cell type-specific regulation of IL-10 expression in inflammation and disease.

Authors:  Christian M Hedrich; Jay H Bream
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.